The impact of diet and micronutrient supplements on the expression of neuroendocrine markers in murine Lady transgenic prostate
- PMID: 18188867
- DOI: 10.1002/pros.20692
The impact of diet and micronutrient supplements on the expression of neuroendocrine markers in murine Lady transgenic prostate
Abstract
Background: Neuroendocrine (NE) differentiation (NED) in prostate cancer (PCa) is associated with morbidity and death; however, the underlying cause(s) promoting NED in PCa have yet to be determined. In this study, we examined the effect of both diet and micronutrient supplementation on the expression of NE markers using the Lady (12T-10) transgenic model of PCa. Lady (12T-10) transgenic animals develop advanced adenocarcinoma with NE characteristics that exhibits metastases in approximately 80% of cases. In this model a high fat diet has been shown to increase the severity of disease, while the use of micronutrients can inhibit this progression.
Methods: In this study we used immunohistochemical analysis to determine expression of the NE markers: chromogranin A (CgA), neuron-specific enolase (NSE), bombesin, parathyroid hormone-related peptide (PTHrP), neurotensin and serotonin in prostates of PCa-bearing Lady (12T-10) mice.
Results: High fat diet was correlated with significantly elevated expression of CgA and serotonin in prostate tissue of Lady (12T-10) mice. Addition of micronutrients to the control and high fat diet reproducibly elevated PTHrP and bombesin expression and suppressed NSE expression, while prostate tissue from the control diet supplemented with micronutrients exhibited significantly lower numbers of calcitonin- and neurotensin-positive cells.
Conclusions: These results highlight the importance of dietary control in management of disease and identify differential changes in NE marker expression, which may be diagnostically viable in monitoring the impact of therapies on disease status.
Copyright 2008 Wiley-Liss, Inc.
Similar articles
-
Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.Endocr Relat Cancer. 2006 Mar;13(1):151-67. doi: 10.1677/erc.1.01043. Endocr Relat Cancer. 2006. PMID: 16601285
-
A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.Cancer Res. 2001 Mar 1;61(5):2239-49. Cancer Res. 2001. PMID: 11280793
-
Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.Cancer Res. 1999 Aug 1;59(15):3821-30. Cancer Res. 1999. PMID: 10447001
-
Neuroendocrine differentiation in the progression of prostate cancer.Int J Urol. 2009 Jan;16(1):37-44. doi: 10.1111/j.1442-2042.2008.02175.x. Int J Urol. 2009. PMID: 19120524 Review.
-
The neuroendocrine phenotype in prostate cancer: basic and clinical aspects.J Endocrinol Invest. 2005;28(11 Suppl International):141-5. J Endocrinol Invest. 2005. PMID: 16625864 Review.
Cited by
-
Diabetes mellitus secondary to endocrine diseases: a position statement of the working group of the club of the Italian society of endocrinology (SIE)-Nutrition hormones and metabolism.J Endocrinol Invest. 2025 Aug;48(8):1739-1758. doi: 10.1007/s40618-025-02589-2. Epub 2025 Apr 28. J Endocrinol Invest. 2025. PMID: 40293649 Review.
-
Role of diet in prostate cancer: the epigenetic link.Oncogene. 2015 Sep 3;34(36):4683-91. doi: 10.1038/onc.2014.422. Epub 2014 Dec 22. Oncogene. 2015. PMID: 25531313 Free PMC article. Review.
-
Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer.Nutrients. 2022 Feb 18;14(4):851. doi: 10.3390/nu14040851. Nutrients. 2022. PMID: 35215499 Free PMC article. Review.
-
Mouse models of prostate cancer: picking the best model for the question.Cancer Metastasis Rev. 2014 Sep;33(2-3):377-97. doi: 10.1007/s10555-013-9487-8. Cancer Metastasis Rev. 2014. PMID: 24452759 Free PMC article. Review.
-
Nutritional aspects in neuroendocrine neoplasms. bridging the gap between dietary interventions and cancer care strategies: a scoping review.J Endocrinol Invest. 2025 Feb;48(2):269-281. doi: 10.1007/s40618-024-02462-8. Epub 2024 Oct 12. J Endocrinol Invest. 2025. PMID: 39395115 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials